Users will be able to access DeepScribe’s documentation platform through AWS.
DeepScribe announced that its ambient AI clinical documentation software is available as a purchasing option on Amazon’s AWS Marketplace.1 This includes the entirety of Deepscribe’s platform, including Customization Studio, Clinical Moments, and Real-Time. Healthcare organizations will have the ability to deploy ambient AI that integrates directly with their HER.
In a press release, DeepScribe co-founder and COO said, “Our inclusion in the AWS Marketplace is made possible by our work with AWS as well as the integrity of our enterprise-ready AI clinical documentation solution. The increased accessibility will enable enterprise healthcare organizations to consolidate their cloud spend and more easily deploy DeepScribe to address the critical issue of clinician burnout as it automates clinical documentation, improves efficiency, and allows greater focus on delivering patient care."
In the same press release, Deepscribe’s co-founder and CEO Akilesh Bapu said, “Healthcare systems are moving fast to adopt the AI stack of the future, from ambient AI to clinical decision support. We think it's important to make rolling out this stack as seamless as possible–with this, rolling out DeepScribe is easier than ever, directly through AWS."
In February, Deepscribe announced that it had partnered with Amazon Web Services (AWS) to develop and scale large language models for healthcare. In a press release,2 Deepscribe stated that, as part of this partnership, it would incorporate AWS HealthScribe onto its platform.
In a press release issued at the time, Covenant HealthCare vice president and chief information officer Frank Fear said, “We're extremely excited about the transformative potential DeepScribe's AI technology brings to our health system. DeepScribe is empowering us to alleviate the documentation burden, deliver exceptional patient care, and make good on our commitment to prioritize clinician well-being."
In the same press release, Bapu added, “We are excited to be working with AWS to eliminate the burden of documentation for exponentially more providers and unlock better, more accurate medical reasoning capabilities. AWS generative AI services, paired with our dataset, will allow us to push the boundaries of AI in care delivery.”
According to Deepscribe, it had already processed and labeled more than 3 million clinical conversations on the platform by February. Due to the nature of these conversations, they were de-identified prior to being processed. This data was used to train multiple LLMs and AI programs to be used within the healthcare landscape.
AWS’ chief medical officer, Jared Saul, said in a press release, “Reducing documentation burden is a prime example of how generative AI can be applied to positively impact clinician and patient experiences. We're excited to be supporting DeepScribe's work in scaling adoption of clinical AI and purpose-built LLMs."
Yvonne Greenstreet: Answering the Call
May 10th 2024From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.
The State of Mining Data Insights in the Life Sciences Industry – 2024
April 30th 2024A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.